Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States
Clinical trial NCT03382418 · COMPLETED
Trial details
- NCT number
- NCT03382418
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-27
- Primary completion
- 2019-09-25
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.